Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells
Acta Pharmaceutica · 01.06.2023 · 73 (2) · 211-225
DOI: 10.2478/acph-2023-0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 12.06.2023. Verfasst von Yuan Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: 1College of Life Science and Technology, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing 100029, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Bladder cancer (BC) is the tenth most commonly diagnosed cancer. High recurrence, chemoresistance, and low response rate hinder the effective treatment of BC. Hence, a novel therapeutic strategy in the clinical management of BC is urgently needed. Medicarpin (MED), an isoflavone from Dalbergia odorifera , can promote bone mass gain and kill tumor cells, but its anti-BC effect remains obscure. This study reve aled that MED effectively inhibited the proliferation and arrested the cell cycle at the G1 phase of BC cell lines T24 and EJ-1 in vitro . In addition, MED could significantly suppress the tumor growth of BC cells in vivo . Mechanically, MED induced cell apoptosis by upregulating pro-apoptotic proteins BAK1, Bcl2-L-11, and caspase-3. Our data suggest that MED suppresses BC cell growth in vitro and in vivo via regulating mitochondria-mediated intrinsic apoptotic pathways, which can serve as a promising candidate for BC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1College of Life Science and Technology, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing 100029, China.
- 2Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
- 3Department of Pathology, First Central Hospital of Baoding City, Baoding 071000, Hebei, China.
- 4Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding 071000, Hebei, China.
- 5Department of Pathology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
- 6College of Life Science and Technology, Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production and Construction Corps, Tarim University, Alar 843300, Xinjiang, China.
ORCID-Profile: Yuan Chen, Liqi Yin, Yuxin Sun, Qiao Wang, Youfeng Liang, Jinku Zhang, Runfen Cheng, Jiansong Wang, Haifeng Wang, Zhao Yang
Zitieren
APA
Chen, Y., Yin, L., Hao, M., Xu, W., Gao, J., Sun, Y., Wang, Q., Chen, S., Liang, Y., Guo, R., Zhang, J., Li, J., Zhai, Q., Cheng, R., Wang, J., Wang, H., & Yang, Z. (2023). Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells. Acta Pharmaceutica, 73(2), 211-225. https://doi.org/10.2478/acph-2023-0016
Vancouver
Chen Y, Yin L, Hao M, Xu W, Gao J, Sun Y, et al. Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells. Acta Pharmaceutica. 2023;73(2):211-225. doi:10.2478/acph-2023-0016
BibTeX
@article{Chen2023,
author = {Chen, Yuan and Yin, Liqi and Hao, Mingxuan and Xu, Wenkai and Gao, Jixian and Sun, Yuxin and Wang, Qiao and Chen, Shi and Liang, Youfeng and Guo, Rui and Zhang, Jinku and Li, Jinmei and Zhai, Qiongli and Cheng, Runfen and Wang, Jiansong and Wang, Haifeng and Yang, Zhao},
title = {Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells},
journal = {Acta Pharmaceutica},
year = {2023},
volume = {73},
number = {2},
pages = {211--225},
doi = {10.2478/acph-2023-0016}
}
EUVIMED